Back to search

Article

The development of multiple reaction monitoring assays for liver-derived plasma.

2007-12-01

Abstract excerpt

There is wide interpatient variability in toxicity to chemotherapeutic drugs and a lack of routine clinical tests for prospectively identifying patients at risk of developing toxicity from chemotherapy. An empirically driven MS strategy has been developed to monitor liver-derived plasma proteins as potential biomarkers of early toxicity. Multiple reaction monitoring (MRM) has been used to assess 46 candidate pepti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f5268b5f-a986-545c-b02a-797ed6a0076e
DOI
10.1002/prca.200700305
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The development of multiple reaction monitoring assays for liver-derived plasma.DOI 10.1002/prca.200700305
Select a neighboring publication to make it the new centre.